Publications: Stephen Ezell

A new proposal to tax university patent royalties would do little to benefit taxpayers while undermining the Bayh-Dole system that drives U.S. innovation, risking America’s global leadership in turning research into real-world breakthroughs.

For the EIA to succeed, the Commission needs to address Europe’s broader economic policy environment. The EU’s reliance on the precautionary principle has entrenched a risk-first mindset that slows innovation and diverts resources away from competition and quality improvement.

Stephen Ezell sat down with Prof. Mahesh Panchagnula to explore the realities of innovation and entrepreneurship.

The mounting economic costs of burdensome regulations that exact far more costs than benefits on societies—and which in many countries have led to unchecked regulatory accumulation—and the adverse impact on innovation, productivity, and long-term growth they cause.

This report ranks more than 200 regions across Argentina, Brazil, Chile, Colombia, Mexico, Peru, and the United States on 13 commonly available indicators of innovation competitiveness, and offers policymakers a guide to bolstering regional and national innovation capacity.

Multi-cancer early detection (MCED) technologies are poised to radically transform the cancer-screening paradigm for the significant benefit of Americans’ individual and public health. Congress can play a critical role in making that transformation happen.

Chinese electric vehicle makers have benefited from aggressive state-sponsored mercantilist policies that have enabled them to produce lower-cost vehicles than foreign competitors can. They should not be allowed to manufacture their products in the United States.

There are many technology policy issues where states have created a patchwork of regulation that impose duplicative costs on businesses, cause confusion for consumers, and act as a drain on the U.S. economy. In order to address these issues, federal preemption would streamline regulation and decrease costs and confusion.

Turning CHIPS Act grants into government equity stakes would undermine their purpose and weaken U.S. efforts to expand domestic semiconductor manufacturing.

Room remains for the Trump administration to better balance the interests of restoring American manufacturing, removing other nations’ unfair trade practices, and orientating like-mined nations to the long-term China threat in the execution of the Trump administration’s trade and tariff policies.